Skip to content

CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFICACY OF KEELVATHATHIRKU PATTRU [EXTERNAL THERAPY] AND KEELVAYU NIVARANA CHOORANAM [INTERNAL] IN AZHAL KEEL VAYU [OSTEOARTHRITIS].

AN OPEN LABELLED NON- RANDOMIZED PHASE II COMPARATIVE CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFICACY OF PATTRU [EXTERNAL THERAPY] AND KEELVAYU NIVARANA CHOORANAM [INTERNAL] FOR AZHAL KEEL VAYU [OSTEOARTHRITIS].

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019912
Enrollment
40
Registered
2019-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Keel Vayu Nivarana Chooranam and Keel vathathirku pattru: Keel Vayu Nivarana Chooranam 10-20 grains (650mg - 1300mg)oral route twice daily. Keel vathathirku pattru External Control Inte

Sponsors

Mohammed Fizel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of joint pain of both knee joints, swelling, tenderness, stiffness, crepitation, restricted movements of both knee joints. Patients who are willing to give blood samples for laboratory investigation . Patients who are willing to take X-ray before and after treatment. Willing for admission in IPD for 48 days or willing to attend OPD regularly. Patients who are willing to participate in this study with knowledge of potential risks and who are willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: Cardiac disease Rheumatoid and other types of arthritis Use of narcotic drugs Pregnant women and lactating mother Trauma, Fracture, Ligament injury Patient with any other serious illness. Benign and malignant neoplasm Immuno compromised Patients Dermatological issues

Design outcomes

Primary

MeasureTime frame
Assessment of change from baseline in WOMAC score at day of 48Timepoint: 48 days

Secondary

MeasureTime frame
Assessment of quality of life by EQ-5DTimepoint: 48 days

Countries

India

Contacts

Public ContactMMohammed Fizel

Govt Siddha Medical College Hospital

dr.ahmed63@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026